Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEFFRY ALAN JACQMEIN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1588624761
CMS profile
117341
Location
JACKSONVILLE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$193.80

2 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $193.80 2

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $126.08 1
AstraZeneca Pharmaceuticals LP $67.72 1

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEFFRY ALAN JACQMEIN

NPI 1588624761 · CMS profile ID 117341

Allopathic & Osteopathic Physicians / Family Medicine

JACKSONVILLE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1588624761?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEFFRY ALAN JACQMEIN, NPI 1588624761, CMS profile ID 117341. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1588624761?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JEFFRY ALAN JACQMEIN, NPI 1588624761, CMS profile ID 117341. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1588624761?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JEFFRY ALAN JACQMEIN, NPI 1588624761, CMS profile ID 117341, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1588624761?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

2 matching records · $193.80 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 2 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–2 of 2.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $126.0811/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141579567 CMS
AstraZeneca Pharmaceuticals LP $67.7205/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105715512 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $193.80 2

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,267,086.60 104
PY2024 Recipient $1,250.00 1
PY2024 Principal investigator $2,152,633.93 77
PY2023 Recipient $1,250.00 1
PY2023 Principal investigator $2,337,900.80 1,040
PY2022 Principal investigator $878,603.36 715
PY2021 Principal investigator $421,556.50 35
PY2020 Principal investigator $639,049.71 93
PY2019 Principal investigator $963,118.36 129

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

35 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Pharmaceuticals, Inc $32,838.00 12/28/2021 Non-covered Recipient Entity
Jacksonville Ctr For Clinic Rsrch
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 787572695
Principal investigator 1 Janssen Pharmaceuticals, Inc $350.00 12/15/2021 Non-covered Recipient Entity
Jacksonville Ctr For Clinic Rsrch
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 787572643
Principal investigator 1 Janssen Pharmaceuticals, Inc $500.00 12/15/2021 Non-covered Recipient Entity
Jacksonville Ctr For Clinic Rsrch
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 787572655
Principal investigator 1 Janssen Pharmaceuticals, Inc $1,500.00 12/15/2021 Non-covered Recipient Entity
Jacksonville Ctr For Clinic Rsrch
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 787572665
Principal investigator 1 Janssen Pharmaceuticals, Inc $8,000.00 12/15/2021 Non-covered Recipient Entity
Jacksonville Ctr For Clinic Rsrch
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 787572683
Principal investigator 1 Janssen Pharmaceuticals, Inc $3,000.00 12/13/2021 Non-covered Recipient Entity
Jacksonville Ctr For Clinic Rsrch
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 787572675
Principal investigator 1 Janssen Pharmaceuticals, Inc $40,380.00 11/22/2021 Non-covered Recipient Entity
Jacksonville Ctr For Clinic Rsrch
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 787572705
Principal investigator 1 ABBVIE INC. $2,026.00 11/09/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792481737
Principal investigator 1 Seqirus USA Inc $1,100.00 10/15/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515833
Principal investigator 1 Seqirus USA Inc $1,000.00 10/15/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515843
Principal investigator 1 Seqirus USA Inc $580.00 10/15/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515849
Principal investigator 1 Seqirus USA Inc $728.00 10/15/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515859
Principal investigator 1 Amgen Inc. $21,225.36 10/08/2021 Non-covered Recipient Entity
ENCORE RSRCH GROUP-JACKSONVILLE CTR
Interchangeability Study - ABP 654 No dispute reported 06/30/2026 830982989
Principal investigator 1 ABBVIE INC. $1,176.50 10/07/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792477997
Principal investigator 1 ABBVIE INC. $599.90 09/08/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792474189
Principal investigator 1 Amgen Inc. $152.14 08/30/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL
Interchangeability Study - ABP 654 No dispute reported 06/30/2026 830983019
Principal investigator 1 ABBVIE INC. $2,337.90 07/29/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792469329
Principal investigator 1 ABBVIE INC. $750.00 07/27/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792468607
Principal investigator 1 GlaxoSmithKline, LLC. $28,395.40 06/23/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL
Not supplied No dispute reported 06/30/2026 809491379
Principal investigator 1 Seqirus USA Inc $2,332.80 06/11/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515599
Principal investigator 1 Seqirus USA Inc $146.00 05/21/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515583
Principal investigator 1 SANOFI PASTEUR INC. $11,250.00 05/19/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
MEQ00066 Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal MenACYW Conjugate Vaccine in Older Adults Who Received a Primary Vaccination 3 or More Years Earlier in Study MET49 No dispute reported 06/30/2026 838366570
Principal investigator 1 ABBVIE INC. $244.10 05/13/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792457075
Principal investigator 1 Seqirus USA Inc $15,163.20 05/07/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515531
Principal investigator 1 SANOFI PASTEUR INC. $4,750.00 04/23/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
MEQ00066 Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal MenACYW Conjugate Vaccine in Older Adults Who Received a Primary Vaccination 3 or More Years Earlier in Study MET49 No dispute reported 06/30/2026 838366547
Principal investigator 1 Emergent BioSolutions Inc. $6,000.00 04/21/2021 Non-covered Recipient Entity
Jacksonville Center for Clinical Research
A Phase 3 Safety, Immunogenicity, and Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317 in Healthy Adults and Adolescents No dispute reported 06/30/2026 823607741
Principal investigator 1 ABBVIE INC. $1,963.60 04/15/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792445235
Principal investigator 1 Seqirus USA Inc $583.20 04/12/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515449
Principal investigator 1 ABBVIE INC. $5,799.60 03/19/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792434413
Principal investigator 1 Seqirus USA Inc $761.40 03/10/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515257
Principal investigator 1 Seqirus USA Inc $5,406.30 02/11/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808515241
Principal investigator 1 ABBVIE INC. $459.90 01/21/2021 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792410639
Principal investigator 1 Biogen, Inc. $217,722.00 01/14/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 No dispute reported 06/30/2026 828998827
Principal investigator 1 Seqirus USA Inc $1,258.20 01/12/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808514881
Principal investigator 1 Seqirus USA Inc $1,077.00 01/07/2021 Non-covered Recipient Entity
Jacksonville Center For Clinical Research
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults No dispute reported 06/30/2026 808514867